Search by Drug Name or NDC
NDC 49230-0534-25 Venofer 20 mg/mL Details
Venofer 20 mg/mL
Venofer is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Medical Care Holdings, Inc.. The primary component is IRON SUCROSE.
MedlinePlus Drug Summary
Iron sucrose injection is used treat iron-deficiency anemia (a lower than normal number of red blood cells due to too little iron) in people with chronic kidney disease (damage to the kidneys which may worsen over time and may cause the kidneys to stop working). Iron sucrose injection is in a class of medications called iron replacement products. It works by replenishing iron stores so that the body can make more red blood cells.
Related Packages: 49230-0534-25Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Iron Sucrose Injection
Product Information
NDC | 49230-0534 |
---|---|
Product ID | 49230-534_a21a525d-9e5a-41e1-9415-bf362352f4b5 |
Associated GPIs | 82300048002020 |
GCN Sequence Number | 047038 |
GCN Sequence Number Description | iron sucrose complex VIAL 100 MG/5ML INTRAVEN |
HIC3 | C3B |
HIC3 Description | IRON REPLACEMENT |
GCN | 86371 |
HICL Sequence Number | 021773 |
HICL Sequence Number Description | IRON SUCROSE COMPLEX |
Brand/Generic | Brand |
Proprietary Name | Venofer |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | iron sucrose |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 20 |
Active Ingredient Units | mg/mL |
Substance Name | IRON SUCROSE |
Labeler Name | Fresenius Medical Care Holdings, Inc. |
Pharmaceutical Class | Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA021135 |
Listing Certified Through | 2024-12-31 |
Package
NDC 49230-0534-25 (49230053425)
NDC Package Code | 49230-534-25 |
---|---|
Billing NDC | 49230053425 |
Package | 25 VIAL, SINGLE-DOSE in 1 TRAY (49230-534-25) / 5 mL in 1 VIAL, SINGLE-DOSE (49230-534-01) |
Marketing Start Date | 2008-11-04 |
NDC Exclude Flag | N |
Pricing Information | N/A |